Both in Pharmaceuticals
Amylyx Pharmaceuticals vs Disc Medicine
Over the past year AMLX returned +112.2% and IRON returned −4.5%; their daily moves had a correlation of 0.23.
AMLX +112.2% IRON −4.5%Growth of $1, one year, split-adjusted
| Metric | AMLX | IRON |
|---|---|---|
| Price | $28.86 | $80.84 |
| Market cap | $3.62B | $3.59B |
| Today | +0.63% | −2.41% |
| 1 month | +2.8% | +27.1% |
| 6 months | +80.3% | +20.8% |
| Year to date | +138.9% | +1.8% |
| 1 year | +107.8% | −4.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $250.8M | $658.4M |
| Dividend yield | — | — |
| Volatility (60d) | 112.7% | 75.7% |
| Short % of float | 13.7% | 22.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).